RYR1 and Malignant hyperthermia: Diagnostic RYR1 screening of selected exons has been established for malignant hyperthermia patients by a number of laboratories associated with the European Malignant Hyperthermia Group (EMHG) [83] however, patients with MmD are likely to require sequencing of the entire RYR1 coding sequence currently not widely available.